NCT06065163 - Ultrasound Guided Diuretic Therapy in Type 1 Cardiorenal Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions

Cardiorenal Syndrome Type 1

Interventions

OTHER

Diuretic de/escalation based on ultrasound findings (VExUS Score)

Patients allocated in the experimental arm will have diuretic dosing adjusted based on ultrasound findings (VExUS Score)

OTHER

Diuretic de/escalation based on clinical findings (CCS Score)

Patients allocated in the experimental arm will have diuretic dosing adjusted based on clinical findings (CCS Score)

Trial Locations (1)

RECRUITING

Instituto Nacional de Cardiología Ignacio Chávez, Mexico City